1. Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany;
2. Institute of Human Genetics, Christian-Albrechts University Kiel & University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany;
3. Bioinformatics and Omics Data Analytics, German Cancer Research Center (DKFZ), Heidelberg, Germany;
4. Faculty of Biosciences,
5. Cell Networks, Bioquant, and
6. Institute of Pharmacy and Molecular Biotechnology and Bioquant, University of Heidelberg, Heidelberg, Germany;
7. Division of Theoretical Bioinformatics, DKFZ, Heidelberg, Germany;
8. Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany;
9. Cologne Center for Genomics, Center for Molecular Medicine Cologne and
10. Cologne Center for Genomics, University of Cologne, Cologne, Germany;
11. Department of Pediatric Immunology, Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany;
12. Institute of Functional Genomics, University of Regensburg, Regensburg, Germany;
13. Hematopathology Section, Christian-Albrechts University, Kiel, Germany;
14. Department of Pediatric Hematology and Oncology and NHL-BFM Study Center, University Hospital Münster, Münster, Germany;
15. Department of Clinical Pathology, Robert-Bosch Krankenhaus, and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany;
16. Section of Pathology, Department of Medical Biotechnology, University of Siena, Siena, Italy;
17. Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; and
18. Flow Cytometry Laboratory, Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie Institute–Oncology Center, Warsaw, Poland